The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law There's a lot of noise around peptides right now so here's what actually changed. The FDA has begun reviewing several peptides that were previously placed on its do not compound list. By RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion